RIM
CRL icon

Redwood Investment Management’s Charles River Laboratories CRL Stock Holding History

Redwood Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
+5,132
New +$914K 0.12% 159
2026
Q1 		– Sell
-5,477
Closed -$1.09M – 278
2025
Q4 		$1.09M Buy
+5,477
New +$993K 0.12% 163

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Redwood Investment Management's CRL Position: Q2 2026 in Review

Redwood Investment Management opened a new position in Charles River Laboratories (CRL) in Q2 2026: 5,132 shares worth $1.16M. The stake represents 0.12% of the portfolio and ranks #159 among its holdings. This is a return to the name: Redwood Investment Management previously reported a position in CRL as recently as Q4 2025.

Redwood Investment Management first reported a position in CRL in Q4 2025 and has held it in 2 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Redwood Investment Management held 5,132 shares of Charles River Laboratories worth $1.16M as of Q2 2026.
  • Charles River Laboratories was a new Redwood Investment Management position in Q2 2026.
  • Charles River Laboratories made up 0.12% of Redwood Investment Management's portfolio in Q2 2026, its #159 holding.
  • Redwood Investment Management first reported a position in Charles River Laboratories in Q4 2025 and has held it in 2 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Redwood Investment Management's 13F filing for Q2 2026, filed 17 Aug 2026.